期刊专题

10.3969/j.issn.1671-8348.2013.04.040

Non-invasive assessment of liver fibrosis

引用
@@ 1 IntroductionLiver fibrosis is a scar forming process which results from the repair and proliferation of liver tissue associated with increased deposition of extracellular matrix (ECM) in liver after diverse liver injuries.A liver biopsy remains the gold standard for assessing liver fibrosis.However,liver biopsy is an invasive procedure with several limitations.Direct serum markers are used for assessing the degree of liver fibrosis and guiding treatment in clinical practice.Serum HA levels were more clinically useful for diagnosing and predicting the absence or presence of significant fibrosis than mild and moderate fibrosis.The increase of serum PIIINP levels prompted active liver fibrosis in the early stage of CLD and reflected the activity of inflammation.Serum CIV levels significantly increased with the early progression of fibrogenesis and serum laminin has a strongly positive correlation with the degree of portal hypertension.Non-patented serum marker indexes are more used in clinical practice when patented.But none of these can exactly reflect liver fibrosis.

liver fibrosis、clinical practice、liver biopsy、extracellular matrix、portal hypertension、forming process、used in

42

R5 ;R44

2013-03-21(万方平台首次上网日期,不代表论文的发表时间)

共5页

454-458

相关文献
评论
暂无封面信息
查看本期封面目录

重庆医学

1671-8348

50-1097/R

42

2013,42(4)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn